Brazil orders divestiture for GSK/Pfizer
Brazil’s competition authority has ordered Pfizer to divest its antacid tablet business to move forward with its proposed joint venture with GlaxoSmithKline.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.